These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 23606278

  • 1. Beyond statins: lipid management to reduce cardiovascular risk.
    Schuck RN, Mendys PM, Simpson RJ.
    Pharmacotherapy; 2013 Jul; 33(7):754-64. PubMed ID: 23606278
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia.
    Jacobson TA.
    Int J Clin Pract; 2011 Jan; 65(1):82-101. PubMed ID: 21105969
    [Abstract] [Full Text] [Related]

  • 5. Lipid-lowering agents.
    Ewang-Emukowhate M, Wierzbicki AS.
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):401-11. PubMed ID: 23811423
    [Abstract] [Full Text] [Related]

  • 6. Recent clinical studies of the effects of lipid-modifying therapies.
    Gotto AM, Moon JE.
    Am J Cardiol; 2012 Jul 01; 110(1 Suppl):15A-26A. PubMed ID: 22697388
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intensive statin therapy for Indians: Part-I. Benefits.
    Enas EA, Pazhoor HC, Kuruvila A, Vijayaraghavan K.
    Indian Heart J; 2011 Jul 01; 63(3):211-27. PubMed ID: 22734339
    [Abstract] [Full Text] [Related]

  • 10. Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial with previous surrogate endpoint trials.
    Michos ED, Sibley CT, Baer JT, Blaha MJ, Blumenthal RS.
    J Am Coll Cardiol; 2012 Jun 05; 59(23):2058-64. PubMed ID: 22520249
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    J Am Coll Cardiol; 2004 Aug 04; 44(3):720-32. PubMed ID: 15358046
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 04; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK, Drexel H, Feely J, Ferrières J, Gonzalez-Juanatey JR, Thomsen KK, Leiter LA, Lundman P, da Silva PM, Pedersen T, Wood D, Jünger C, Dellea PS, Sazonov V, Chazelle F, Kastelein JJ, DYSIS Investigators.
    Eur J Prev Cardiol; 2012 Apr 04; 19(2):221-30. PubMed ID: 21450578
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].
    Brath H, Wascher TC, Kästenbauer T, Toplak H.
    MMW Fortschr Med; 2012 Jun 28; 154 Suppl 2():41-7. PubMed ID: 23424754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.